Artelo Biosciences Inc. (ARTLW)
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
SELLA CAPITAL REAL ESTATE LTD (SLARL)
Change in holdings of interested parties/officers
ARTELO BIOSCIENCES, INC. (ARTL)
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
SKYX PLATFORMS CORP. (SKYX)
SKYX Announces Corporate Update Call
ERASCA, INC. (ERAS)
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
CITROTECH INC. (CITR)
CitroTech Provides Q2 2026 Business Update in Letter to Shareholders
HBT FINANCIAL, INC. (HBT)
HBT Financial, Inc. and Tri-County Financial Group, Inc. Jointly Announce Strategic Transaction
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution AdvancingAmpligen® Toward Planned Phase 3 Development in Pancreatic Cancer
AIM IMMUNOTECH INC. (AIM)
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
VIA TRANSPORTATION, INC. (VIA)
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Via Transportation (VIA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026